STOCK TITAN

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2020

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Cantel Medical Corp (NYSE:CMD) will announce its first-quarter results on December 8, 2020, prior to market opening, covering the period ending October 31, 2020. A conference call will follow at 8:30 a.m. ET to discuss the financial outcomes. Participants can join by dialing 1-844-602-0380 for US and Canada, or 1-862-298-0970 for international calls. A replay will be available post-call until January 7, 2021. Cantel Medical specializes in infection prevention products aimed at improving healthcare outcomes.

Positive
  • Scheduled earnings release for Q1 results indicates ongoing transparency.
  • Company specializes in innovative infection prevention solutions.
Negative
  • None.

LITTLE FALLS, N.J., Nov. 24, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its first quarter ended October 31, 2020 on Tuesday, December 8, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.

To participate in the conference call, dial 1-844-602-0380 (US & Canada) or 1-862-298-0970 (International) approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Tuesday, December 8, 2020 through midnight on January 7, 2021 by dialing 1-877-481-4010 (US & Canada) or 1-919-882-2331 (International) and using conference ID# 38447.

An audio webcast will be available via the Cantel website at www.cantelmedical.com. A replay of the presentation will be archived on the Cantel website for those unable to listen live. In addition, the Company will provide a supplemental presentation to complement the conference call. The presentation can be accessed on Cantel's website in the Investor Relations section under presentations.

About Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, instruments and instrument reprocessing workflow systems serving the dental industry, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.

For further information, visit www.cantelmedical.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cantel-medical-corp-to-hold-conference-call-to-discuss-results-for-its-first-quarter-ended-october-31-2020-301179302.html

SOURCE Cantel Medical Corp.

FAQ

When will Cantel Medical Corp release its Q1 2020 earnings report?

Cantel Medical Corp will release its Q1 2020 earnings report on December 8, 2020.

What time is the conference call for Cantel Medical's Q1 results?

The conference call for Cantel Medical's Q1 results is scheduled for 8:30 a.m. ET on December 8, 2020.

How can I listen to Cantel Medical's conference call?

To listen to Cantel Medical's conference call, dial 1-844-602-0380 (US) or 1-862-298-0970 (International).

CMD

NYSE:CMD

CMD Rankings

CMD Latest News

CMD Stock Data

35.24M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Little Falls